S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
ASX:PNV

PolyNovo (PNV) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.38 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PNV stock logo

About PolyNovo (ASX:PNV) Stock

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

PNV Stock News Headlines

“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
PolyNovo Limited (ASX:PNV) Not Flying Under The Radar
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
PolyNovo Limited (ASX:PNV) Is About To Turn The Corner
PolyNovo share price jumps 11% on FDA update
Polynovo share price halted amid FDA news
See More Headlines


Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
122
Year Founded
N/A

Profitability

Net Income
$-6,630,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$53.12 million
Book Value
A$0.09 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.45

Key Executives

  • Mr. Jan-Marcel Gielen C.A.
    CFO & Company Sec.
  • Dr. David McQuillan Ph.D.
    Chief Technical & Scientific Officer
  • Mr. Swami Raote BPHARM
    M.B.A., CEO & Director
  • Mr. Ahmed Hassan
    Director of Operations
  • Ms. Teena Chadha
    APAC Marketing & Distributor Mang.
  • Ms. Monica Benyk
    HR Mang.
  • Dr. Tim Moore
    Principal Scientist
  • Mr. Edward Graubart
    Sr. VP of Sales & Marketing (Americas)













PNV Stock - Frequently Asked Questions

What other stocks do shareholders of PolyNovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma (SPL), Moelis Australia (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

What is PolyNovo's stock symbol?

PolyNovo trades on the ASX under the ticker symbol "PNV."

How much money does PolyNovo make?

PolyNovo (ASX:PNV) has a market capitalization of $0.00 and generates $53.12 million in revenue each year. The company earns $-6,630,000.00 in net income (profit) each year or A($0.01) on an earnings per share basis.

How many employees does PolyNovo have?

The company employs 122 workers across the globe.

How can I contact PolyNovo?

The official website for the company is www.polynovo.com.au. The company can be reached via phone at 61 3 8681 4050.

This page (ASX:PNV) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -